Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ezetimibe

It lowers cholesterol by blocking its absorption in the gut, and was approved in 2002. It is often combined with a statin, which instead blocks cholesterol production in the liver. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It was found while searching for a medicine with a different mechanism: its real target, the NPC1L1 protein, was only identified in 2004, two years after approval.

EzetimibeGo to the active ingredient →
EzetimibeActive ingredientEzetimibeCat. No. P-E150-001CAS 163222-33-1
Ezetimibe-13C6Isotopically labelledEzetimibe-13C6Cat. No. P-E150-008CAS 438624-68-1
Ezetimibe-d4Isotopically labelledEzetimibe-d4Cat. No. P-E150-010CAS 1093659-90-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.